fbpx

Recent News News

How Coranavirus (COVID-19) can affect your eyes

In a recent study on COVID-19 published in JAMA Ophthalmology found that 31.6% of 38 consecutive patients with COVID-19 seen at the Yichang Central People’s Hospital in Hubei Province, China, had eye-related symptoms. Here are some tips to avoid COVID-19 infecting your eyes: Wash hands with soap for at least 20 seconds. Do not touch your face […]Read More >

Message to Our Patients About COVID-19/Coronavirus

We are here for you! Ophthalmic Consultants of the Capital Region is committed to keeping our patients and staff safe during the COVID-19 pandemic while continuing to provide quality care.  Our practice remains open for Urgent and Emergency in-person visits, and in addition, we are pleased to announce that we’re now offering telehealth appointments, which […]Read More >

Dr. Allen W. Zieker has been selected by The Global Who’s Who as a Top Doctor Albany, NY– Dr. Allen W. Zieker has been selected by The Global Who’s Who as a Top Doctor for outstanding contributions and achievements in the field of Cataract Surgery. About Dr. Allen W. Zieker Dr. Allen W. Zieker earned his M.D. at the […]Read More >

Vote Now! Dr. Allen Zieker and Dr. David Rabady Nominated for Best Ophthalmologist in 2019 Best of the Best People’s Choice Awards

Schenectady’s The Daily Gazette is currently hosting its 2019 Best of the Best People’s Choice Awards, and both Dr. Allen Zieker and Dr. David Rabady of Ophthalmic Consultants of the Capital Region have been nominated for Best Ophthalmologist. The Best of the Best People’s Choice Awards by The Daily Gazette aims to find the people, […]Read More >

Dr. Allen W. Zieker among first 10 surgeons in U.S. to implant DEXTENZA® device for pain management following ophthalmic surgery.  

Albany, New York—May, 30 2019 Allen W. Zieker, M.D., President and Director of Cataract Surgery at Ophthalmic Consultants of the Capital Region, is the first surgeon in the entire Northeast, including New York City, to implant the DEXTENZA® device in ophthalmic surgery patients. DEXTENZA, from the biopharmaceutical company Ocular Therapeutix™, Inc., was approved for use […]Read More >

ALLEN W. ZIEKER, M.D. FIRST SURGEON IN UNITED STATES TO IMPLANT THE ENVISTA® TORIC MX60T INTRAOCULAR LENS (IOL) IN CATARACT PATIENTS

Albany, NY: Allen W. Zieker, M.D., President and Director of Cataract Surgery at Ophthalmic Consultants of the Capital Region, was chosen to be the first cataract surgeon in the United States to implant the new Bausch + Lomb enVista® toric MX60T intraocular lens. Bausch + Lomb, a leading global eye health company, announced they received […]Read More >

Lyme Disease and Your Eyes

By: Robert B. Feldman, M.D. Board-Certified Ophthalmologist & Retina Specialist at Ophthalmic Consultants of the Capital Region Lyme disease is very prevalent in upstate New York. At Ophthalmic Consultants of the Capital Region, we’re seeing more and more patients this time of year with vision problems caused by Lyme disease. Lyme disease is a tick-borne […]Read More >

New Year, New Vision

It’s 2018 and along with all the New Year’s resolutions, you’re making make sure you’re thinking about your eyes! We recommend our patients call us in January to schedule their annual eye exam. By planning ahead, you get the time and day you want and you can scratch it off your “to do” list. It’s […]Read More >

FSA for Eye Care

Don’t Wait Until December 31 to Spend Your Flexible Spending Account (FSA) Funds on Eye Care (USE IT OR LOSE IT) Now is the time to take advantage of using your FSA for your eye care needs. Schedule an eye exam today to ensure you stay on top of your eye health. Q: So what […]Read More >

Call Now Button